Latest News

February 18, 2019

ACTA Trial of the Year Awards 2019: Call for nominations

Read more

February 4, 2019

ACTA Congratulates ANZCHOG and COGNO on funding success to fight brain cancer

Read more

February 4, 2019

ACTA Efficient and Effective CTNs Reference Group Toolkit now available

Read more

February 4, 2019

ACTA now on LinkedIn – Connect with us!

Read more

February 4, 2019

ACTA Summit Summary

Read more

The ACTA Community


The development of ACTA is supported by more than 50 individual clinical trials networks, clinical trial coordinating centres and clinical quality registries.

These groups bring together hundreds of doctors, nurses, allied health and research professionals to generate evidence about which treatments work, which don’t, and which are most cost-effective for the Australian health system.

More

Twitter


Check out this exciting speaker highlight for the upcoming ACTA International Clinical Trials Conference! Remember to keep your eyes peeled for the opening of registrations on 1st March 2019: https://t.co/pJrrV4yPfN

Community acquired staph is increasing and we have limited understanding of the optimal treatment strategies - Prof Steven Tong, will an Adaptive Platform Trial provide answers? Great work by the network #clinicaltrials https://t.co/asamENLyJV ACTAcommunity photo

Statistician Claire Galea talks neonatal stem cell trials and the quest for the highest quality and most reliable data, with novel trial design approaches. Huge body of scoping work underway to help inform decisions #clinicaltrials https://t.co/XV1SFSoCtY ACTAcommunity photo

Prof Anne Cust kicks of the 2nd day of the ACTA innovative trials ‘hands-on’ workshop, discussing considerations of national melanoma screening trial & the potential role of an adaptive design. Fantastic to hear the such progressive work #clinicaltrials https://t.co/CkSOeeJ3z4 ACTAcommunity photo

Prof Rachael Morton discusses grappling with the economic considerations of novel trial designs #clinicaltrials #healtheconomics https://t.co/K5ndWcXJlS ACTAcommunity photo

The cost of trials are rising, Prof Mustafa Khasraw @mkhasraw and Scott Berry propose how novel trial designs can help address this issue #clinicaltrials #healtheconomics https://t.co/ntDgl4rqKQ ACTAcommunity photo

Prof Leonid Churilov on adaptive randomisation - "the ability to invest sample size resources in stages" #clinicaltrials https://t.co/zqPu02EOJd ACTAcommunity photo

Colin McArthur talking about how the REMAP-CAP trial protocol can be readily utilised in the event of a pandemic declaration #clinicaltrials @remap_cap @BerryConsultant https://t.co/vH3wvCt0VZ ACTAcommunity photo

Adaptive trials much like ‘heat-seeking missiles’ - Dr Tom Snelling #clinicaltrials at ACTA workshop. Opportunities for a learning healthcare system #embeddingresearch https://t.co/y2QwEFxFlZ ACTAcommunity photo

Reconfiguring the landscape, Scott Berry talks about the benefits of platform trials #clinicaltrials. Are we ready for the challenge? https://t.co/Fj6cLXiHLJ ACTAcommunity photo

Bayesian statistics ‘logical and on the rise’ says Prof Jeffrey Presneill - ACTA innovative trial design workshop #clinicaltrials https://t.co/0LtmSxUbjj ACTAcommunity photo

Why does the research community need to consider innovative trial design? Dr Julie Marsh provides interesting insights from UK #clinicaltrials https://t.co/Edsb8S2vk1 ACTAcommunity photo

Prof Stephane Heritier providing an excellent opening session on Adaptive Trial Designs. Exciting ACTA ‘Introduction to Innovative Trials’ workshop ahead #clinicaltrials #stats @georgeinstitute https://t.co/WhAcGynRTJ ACTAcommunity photo

The ACTA International Clinical Trials Conference 2019 program is coming together! Great national and international speakers are already on board.
https://t.co/mLkGq5aWc9
@ACTAcommunity #clinicaltrials #internationalconference https://t.co/37BzyZ3VBx
ACTAcommunity photo

Prof Ian Harris demonstrated innovative ways to streamline patient consent and data collection and consequently decrease trial coordination and site burden. Significantly decreases costs associated with traditional clinical trials.
#clinicaltrials https://t.co/6y8EalFwIU
ACTAcommunity photo

Subscribe for updates

Receive regular updates from ACTA. Enter your details below and Subscribe